Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response-Reference-Cited by-同舟云学术

Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response

Published:2019-07-03 Issue:11 Volume:39 Page:2174-2183
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Mücke Victoria T.¹^ORCID,Thomas Dominique²,Mücke Marcus M.¹^ORCID,Waidmann Oliver¹,Zeuzem Stefan¹,Sarrazin Christoph¹³,Pfeilschifter Josef⁴,Vermehren Johannes¹,Finkelmeier Fabian¹^ORCID,Grammatikos Georgios¹⁵

Affiliation:

1. Universitätsklinikum Frankfurt Frankfurt am Main Germany

2. Pharmazentrum Frankfurt, Institut für Klinische Pharmakologie Frankfurt am Main Germany

3. St. Josefs‐Hospital Wiesbaden Germany

4. Pharmazentrum Frankfurt, Institut für Allgemeine Pharmakologie und Toxikologie Frankfurt am Main Germany

5. St. Luke’s Hospital Thessaloniki Panorama Greece

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14178

Reference48 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

3. Hepatocellular carcinoma

4. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics;Dhanasekaran R;Hepat Med,2012

5. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs;Annals of Hepatology;2024-09

2. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication;Clinical and Molecular Hepatology;2024-07-01

3. Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses;International Journal of Molecular Sciences;2023-04-18

4. Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis;Hepatology;2023-02-23

5. The altered lipidome of hepatocellular carcinoma;Seminars in Cancer Biology;2022-11